Looking Forward: Leadership in a Global Economy
October 20, 2009
Los Angeles
Aspiriant Chief Investment Officer, Dr. Jason Thomas, and chief political strategist with the Washington Research Group, Greg Valliere, discuss the current investment and regulatory environment. Their discussion is followed by Tim Kochis transitioning his role as Chief Executive Officer to Rob Francais. Rob shares a bit about himself and his view for the future.
Aspiriant, LLC, is a registered investment advisor. Information presented in the video clips is not meant as a general guide to investing, or as a source of any specific investment recommendations and Aspiriant makes no implied or express recommendations concerning the manner in which any client’s or viewer’s accounts should or would be handled, as appropriate investment decisions depend upon that party’s individual investment objectives. From time to time, Aspiriant provides vidoe clips for its clients and friends solely for educational and information purposes and that videop clips are not intended to be an offer or solicitation, or the basis for any contract to purchase or sell any security or other instrument, for Aspiriant to enter into or arrange any type of transaction as a consequence of any information contained therein, and no offers or sales will be made in jurisdictions in which the offer and sale of such securities or other instruments is not qualified or otherwise exempt from regulation. Nothing discussed in the video clips should be interpreted to state or imply that past results are an indication of future performance. Although we believe the information in the video clips to be accurate, Aspiriant is not responsible for errors or other inaccuracies in the content of the video clips. Statements made by third party participants in the video clips do not necessarily reflect the opinions of Aspiriant and should not be construed as an endorsement by Aspiriant, either expressed or implied.
For a listing of Aspiriant articles and media coverage, please click here
For the most recent
Aspiriant Annual Report,
please click here